Joseph Baroldi sold $1.0M of Ionis Pharmaceuticals (IONS)

Executed Oct 2 2025, disclosed Oct 2 2025, the same day.

Value, as filed

$1.0M

15,000 sh × $68.01

Executed

Oct 2 2025

the trade date, as filed

Disclosed

Oct 2 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JB Joseph Baroldi EVP, Chief Business Officer profile →

Joseph Baroldi (EVP, Chief Business Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $1.0M of IONS (15,000 sh × $68.01, as filed), executed Oct 2 2025.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Joseph Baroldi in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $452K
5,635 sh × $80.16
Exec Jun 26
Filed Jun 30 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $117K
1,626 sh × $71.79
Exec Apr 28
Filed Apr 30 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $419K
5,619 sh × $74.56
Exec Apr 16
Filed Apr 17 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $493K
6,184 sh across 2 lots
Exec Mar 3
Filed Mar 5 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $439K
5,296 sh × $82.96
Exec Jan 30
Filed Feb 2 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $523K
6,907 sh × $75.75
Exec Jan 16
Filed Jan 20 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $113K
1,625 sh × $69.37
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $743K
11,950 sh × $62.16
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET